Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Alzheimer's Disease Programs Initiative (ADPI) - Dementia Capability in Indian Country

    Forecasted

    Funds 36-month cooperative agreements for federally recognized tribes and tribal entities to expand or develop dementia-capable home and community services for Tribal Elders and their caregivers.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Alzheimer's Disease Programs Initiative (ADPI) - States and Community Grants

    Three-year cooperative agreements support states and community organizations in expanding dementia-capable home and community-based services for people with dementia and their caregivers.

    HHS-ACLForecasted Mar 3, 2027$1,000,000Forecasted

    Alzheimer's Disease Programs Initiative (ADPI) - Developing Dementia-Capable Community Health Worker Programs in the National Aging Network

    Cooperative agreements will support dementia-capable community health worker programs in the National Aging Network to improve screening, referrals, care access, and support for people with dementia and caregivers.

    HHS-ACLForecasted May 3, 2027$250,000Forecasted

    Alheimer's Disease Programs Initiative (ADPI) - State Programs for Dementia Specific Respite

    This 36-month program funds State Units on Aging to establish or expand dementia-specific respite services for unpaid family caregivers, using trained providers and independent evaluation.

    HHS-ACLForecasted May 3, 2027$4,000,000Forecasted

    Community Development Block Grant Program for Indian Tribes and Alaska Native Villages

    This grant funds projects that help Indian tribes and Alaska Native villages improve housing, living conditions, and economic opportunities for low- and moderate-income residents.

    HUDForecasted Nov 16, 2026$2,000,000Forecasted

    Alzheimers Drug-Development Program (U01 Clinical Trial Optional)

    This grant supports academic and biotech researchers in developing new drugs to prevent, slow, or treat Alzheimer’s disease through preclinical and early-stage clinical research.

    HHS-NIH11Forecasted Jun 18, 2027Forecasted